Prevest Denpro Ltd
Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.
- Market Cap ₹ 505 Cr.
- Current Price ₹ 421
- High / Low ₹ 608 / 332
- Stock P/E 30.5
- Book Value ₹ 66.9
- Dividend Yield 0.24 %
- ROCE 32.2 %
- ROE 24.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.9%
Cons
- Working capital days have increased from 35.6 days to 63.6 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|
19 | 23 | 28 | 38 | 50 | 54 | |
15 | 17 | 19 | 23 | 30 | 34 | |
Operating Profit | 4 | 5 | 9 | 15 | 20 | 20 |
OPM % | 20% | 23% | 32% | 40% | 40% | 36% |
0 | 2 | 1 | 2 | 2 | 2 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 1 | 1 | 1 |
Profit before tax | 4 | 6 | 9 | 16 | 21 | 21 |
Tax % | 20% | 20% | 23% | 28% | 25% | |
3 | 5 | 7 | 12 | 16 | 17 | |
EPS in Rs | 1,049.12 | 1,757.89 | 252.98 | 9.64 | 13.09 | 13.81 |
Dividend Payout % | 0% | 0% | 0% | 0% | 8% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 30% |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 46% |
TTM: | 27% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 4% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 28% |
Last Year: | 24% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|
Equity Capital | 0 | 0 | 0 | 12 | 12 | 12 |
Reserves | 10 | 15 | 22 | 45 | 61 | 68 |
1 | 2 | 1 | 1 | 0 | 0 | |
4 | 4 | 7 | 6 | 6 | 6 | |
Total Liabilities | 15 | 21 | 31 | 64 | 79 | 86 |
5 | 5 | 5 | 7 | 7 | 15 | |
CWIP | 0 | 0 | 2 | 5 | 17 | 11 |
Investments | 0 | 0 | 0 | 1 | 1 | 1 |
10 | 16 | 23 | 52 | 53 | 58 | |
Total Assets | 15 | 21 | 31 | 64 | 79 | 86 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
3 | 5 | 9 | 7 | 11 | |
-1 | -1 | -2 | -4 | -13 | |
0 | 0 | -1 | 23 | -1 | |
Net Cash Flow | 2 | 4 | 6 | 26 | -3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Debtor Days | 46 | 35 | 48 | 22 | 31 |
Inventory Days | 28 | 59 | 59 | 122 | 139 |
Days Payable | 70 | 72 | 181 | 61 | 40 |
Cash Conversion Cycle | 4 | 22 | -74 | 83 | 130 |
Working Capital Days | 10 | 20 | 3 | 41 | 64 |
ROCE % | 45% | 47% | 40% | 32% |
Documents
Announcements
- Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024 20 Apr
- Compliance Certificate Issued Pursuant To Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended 31St March, 2024 18 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2024.
- Closure of Trading Window 30 Mar
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 29 Mar
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Feb 2022TranscriptPPT
-
Dec 2021TranscriptPPT
Product Portfolio
Company manufactures over 100 dental products which comprise of:
a) Clinical Products: Adhesives, Bonding Agents & Etchants, Auxiliaries, Cement and Liners, Composites, Endodontics, Finishing & Polishing, Impression Materials, Oral Care, Orthodontics, Retraction Materials, Temporaries, and Tooth Whitening. [1]
b) Laboratory Products: Acrylics, Auxiliaries, Base Plates & Waxes, and Gypsum Products. [2]
Marquee Product - Resins: Company is the leading manufacturer of high-quality 3D printing resins designed for fabrication of dental crowns, bridges, inlays, onlays, and veneers. It offers several advantages over traditional fabrication methods.[3]
** Hygiene & Disinfectant** : This product is specifically formulated to combat a broad spectrum of pathogens, including bacteria, viruses, and fungi. These products are designed to target high-touch surfaces, medical devices, and equipment.[4]
Product Application
Their dental products find application in endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and for fabrication of prosthesis in dental laboratories. [5]
Prevest Denpro Limited operates with a business model focused on the manufacturing and distribution of dental materials and equipment.[6]